The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Immunology of the antiphospholipid antibody syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., de Baets, M. H., & van Breda-Vriesman, P. J. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,270
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.
Hughes, G. R. (1983) · BMJ · doi:10.1136/bmj.287.6399.1088 · Cited by 950
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 720
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 576
Carreras, L., Machin, S., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., & Van Assche, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 543
Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., & Koike, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.457 · Cited by 529
Acquired inhibitors of blood coagulation.
Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521
Oosting, J., Derksen, R., Bobbink, I., Hackeng, T., Bouma, B., & de Groot, P. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 488
Cl, C. (1952) · Journal of Clinical Investigation · Cited by 482
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
Blank, M., Cohen, J., Toder, V, & Shoenfeld, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3069 · Cited by 455
Activation of cultured vascular endothelial cells by antiphospholipid antibodies.
Simantov, R., LaSala, J. M., Lo, S. K., Gharavi, A. E., Sammaritano, L. R., Salmon, J. E., & Silverstein, R. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118276 · Cited by 420
De Wolf, F., Carreras, L. O., Moerman, P., Vermylen, J., Van Assche, A., & Renaer, M. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32527-3 · Cited by 411
Schousboe, I. (1985) · Blood · doi:10.1182/blood.v66.5.1086.1086 · Cited by 366
Roubey, R. A. S., Eisenberg, R. A., Harper, M. F., & Winfield, J. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.954 · Cited by 329
Self-citationHeterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor
Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., Suzuki, T., Sumida, T., Yasuda, T., & Koike, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.3885 · Cited by 323
Complete amino acid sequence of human plasma beta 2-glycoprotein I.
Lozier, J., Takahashi, N., & Putnam, F. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3640 · Cited by 323
Branch, D. W., Dudley, D. J., Mitchell, M. D., Creighton, K. A., Abbott, T. M., Hammond, E. H., & Daynes, R. A. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90700-5 · Cited by 318
Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-I
Nimpf, J., Bevers, E. M., Bomans, P. H. H., Till, U., Wurm, H., Kostner, G. M., & Zwaal, R. F. A. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90237-0 · Cited by 303
The protein C anticoagulant pathway.
Esmon, C. T. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.2.135 · Cited by 287
Circulating anticoagulants: a study of 40 cases and a review of the literature.
Margolius, A., Jackson, D. P., & Ratnoff, O. D. (1961) · PubMed · Cited by 278
Hunt, J., & Krilis, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.653 · Cited by 269
Anti-prothrombin antibodies and the lupus anticoagulant
Fleck, R., Rapaport, S., & Rao, L. (1988) · Blood · doi:10.1182/blood.v72.2.512.512 · Cited by 264
Viard, J.-P., Amoura, Z., & Bach, J.-F. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90049-h · Cited by 264
Autoantibodies in pathology and cell biology
Tan, E. M. (1991) · Cell · doi:10.1016/0092-8674(91)90356-4 · Cited by 244
β2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles
Wurm, H. (1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90168-x · Cited by 234
CIRCULATING ANTICOAGULANTS: A STUDY OF 40 CASES AND A REVIEW OF THE LITERATURE
MARGOLIUS, A., JACKSON, D. P., & RATNOFF, O. D. (1961) · Medicine · doi:10.1097/00005792-196105000-00002 · Cited by 232
Rand, J. H., Wu, X.-X., Guller, S., Gil, J., Guha, A., Scher, J., & Lockwood, C. J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90403-0 · Cited by 231
Bajaj, S., Rapaport, S., Fierer, D., Herbst, K., & Schwartz, D. (1983) · Blood · doi:10.1182/blood.v61.4.684.684 · Cited by 224
Pierangeli, S. S., Liu, X. W., Barker, J. H., Anderson, G., & Harris, E. N. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649940 · Cited by 223
Cabiedes, J., Cabral, A. R., & Alarcón-Segovia, D. (1995) · PubMed · Cited by 222
The Risk of Abortion and Stillbirth in Antithrombin-, Protein C-, and Protein S-deficient Women
Jan Sanson, B., Friedrich, P. W., Simioni, P., Zanardi, S., Huisman, M. V., Girolami, A., Wouter ten Cate, J., & Prins, M. H. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650282 · Cited by 220
The Complexity of the Phospholipid Binding Protein Annexin V
van Heerde, W. L., de Groot, P. G., & Reutelingsperger, C. P. M. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653747 · Cited by 211
Arvieux, J., Darnige, L., Caron, C., Reber, G., Bensa, J. C., & Colomb, M. G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649891 · Cited by 210
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
Malia, R. G., Kitchen, S., Greaves, M., & Preston, F. E. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07843.x · Cited by 209
Roubey, R. A., Pratt, C. W., Buyon, J. P., & Winfield, J. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115926 · Cited by 203
Self-citationReid, K. B. M., Bentley, D. R., Campbell, R. D., Chung, L. P., Sim, R. B., Kristensen, T., & Tack, B. F. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90110-6 · Cited by 198
Mangge, H., Kenzian, H., Gallistl, S., Neuwirth, G., Liebmann, P., Kaulfersch, W., Beaufort, F., Muntean, W., & Schauenstein, K. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380209 · Cited by 198
ISOLATION AND PURIFICATION OF A SEROLOGICALLY ACTIVE PHOSPHOLIPID FROM BEEF HEART
Pangborn, M. C. (1942) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)72683-5 · Cited by 196
Moore, J. E., & Lutz, W. B. (1955) · Journal of Chronic Diseases · doi:10.1016/0021-9681(55)90039-4 · Cited by 196
Nimpf, J., Wurm, H., & Kostner, G. M. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90110-9 · Cited by 195
Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigen
Arvieux, J., Roussel, B., Jacob, M. C., & Colomb, M. G. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90047-j · Cited by 188
Cariou, R., Tobelem, G., Bellucci, S., Soria, J., Soria, C., Maclouf, J., & Caen, J. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647634 · Cited by 187
Complete nucleotide and deduced amino acid sequence of human β 2-glycoprotein I
Steinkasserer, A., Estaller, C., Weiss, E. H., Sim, R. B., & Day, A. J. (1991) · Biochemical Journal · doi:10.1042/bj2770387 · Cited by 181
Marciniak, E., & Romond, E. (1989) · Blood · doi:10.1182/blood.v74.7.2426.2426 · Cited by 175
Galli, M., Comfurius, P., Barbui, T., Zwaal, R. F. A., & Bevers, E. M. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656368 · Cited by 174
Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
Oosting, J. D., Derksen, R. H. W. M., Entjes, H. T. I., Bouma, B. N., & de Groot, P. G. (1992) · PubMed · Cited by 174
Papa, N. D., Guidali, L., Spatola, L., Bonara, P., Borghi, M. O., Tincani, A., Balestrieri, G., & Meroni, P. L. (1995) · PubMed · Cited by 167
Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.
Dahlbäck, B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117458 · Cited by 164
Anti β2 glycoprotein I antibodies: detection and association with thrombosis
Martinuzzo, M. E., Forastiero, R. R., & Carreras, L. O. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03317.x · Cited by 163
Laurell, A., & Nilsson, I. M. (1957) · PubMed · Cited by 161
Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complex
Sugi, T., & McIntyre, J. A. (1995) · Blood · doi:10.1182/blood.v86.8.3083.3083 · Cited by 148
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?
Balestrieri, G., Tincani, A., Spatola, L., Allegri, F., Prati, E., Cattaneo, R., Valesini, G., Papa, N. D., & Meroni, P. L. (1995) · Lupus · doi:10.1177/096120339500400208 · Cited by 147
Galli, M., Finazzi, G., Bevers, E. M., & Barbui, T. (1995) · Blood · doi:10.1182/blood.v86.2.617.bloodjournal862617 · Cited by 146
Prekallikrein Inhibition Associated with the Lupus Anticoagulant: A Mechanism of Thrombosis
Sanfelippo, M. J., & Drayna, C. J. (1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/77.3.275 · Cited by 146
Rapaport, S. I., Ames, S. B., & DUVALL, B. J. (1960) · Blood · doi:10.1182/blood.v15.2.212.212 · Cited by 146
Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I
Oostin, J. D., Derksen, R. H. W. M., Entjes, H. T. I., Bouma, B. N., & de Groot, P. G. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648480 · Cited by 143
Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation.
Sthoeger, Z. M., Mozes, E., & Tartakovsky, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6464 · Cited by 139
Antiphospholipid Antibodies Enhance Thrombin-Induced Platelet Activation and Thromboxane Formation
Martinuzzo, M. E., Maclouf, J., Carreras, L. O., & Levy-Toledano, S. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649646 · Cited by 138
Matsuda, J., Saitoh, N., Gohchi, K., Gotoh, M., & Tsukamoto, A. M. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470112 · Cited by 137
Permpikul, P., Rao, L., & Rapaport, S. (1994) · Blood · doi:10.1182/blood.v83.10.2878.2878 · Cited by 128
Shibata, S., Harpel, P. C., Gharavi, A. E., Rand, J. H., & Fillit, H. M. (1994) · Blood · doi:10.1182/blood.v83.9.2532.2532 · Cited by 128
Polz, E., Wurm, H., & Kostner, G. M. (1980) · International Journal of Biochemistry · doi:10.1016/0020-711x(80)90229-3 · Cited by 127
Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus?
Loeliger, A., Alsbach, E. E. J., & Miss, W. T. T. A. O. (1959) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1654385 · Cited by 127
Pengo, V., Biasiolo, A., & Fior, M. G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653721 · Cited by 126
Smirnov, M. D., Triplett, D. A., Comp, P. C., Esmon, N. L., & Esmon, C. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117657 · Cited by 126
Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance
Triplett, D. A. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00001-1 · Cited by 125
Affinity purified anti-cardiolipin and anti-DNA antibodies.
Harris, E. N., Gharavi, A. E., Tincani, A., Chan, J. K., Englert, H., Mantelli, P., Allegro, F., Ballestrieri, G., & Hughes, G. R. V. (1985) · PubMed · Cited by 122
Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems.
Rauch, J., Tannenbaum, M., Tannenbaum, H., et al. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67567-2 · Cited by 120
Shi, W., Chong, B. H., Hogg, P. J., & Chesterman, C. N. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649577 · Cited by 120
Arnett, F. C., Olsen, M. L., Anderson, K. L., & Reveille, J. D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115158 · Cited by 116
β2-Glycoprotein I Deficiency and the Risk of Thrombosis
Bancsi, L. F. J. M. M., van der Linden, I. K., & Bertina, R. M. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648517 · Cited by 114
Shi, W., Chong, B. H., Hogg, P. J., & Chesterman, C. N. (1993) · PubMed · Cited by 114
Interlaboratory variation in antiphospholipid antibody testing
Peaceman, A. M., Silver, R. K., MacGregor, S. N., & Socol, M. L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91569-v · Cited by 108
Platelet Activating Properties of Murine Monoclonal Antibodies to β2-Glycoprotein I
Arvieux, J., Roussel, B., Pouzol, P., & Colomb, M. G. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649576 · Cited by 91
Pierangeli, S. S., Harris, E. N., Davis, S. A., & DeLorenzo, G. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06468.x · Cited by 89
Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors
Edson, J. R., Vogt, J., & Hasegawa, D. (1984) · Blood · doi:10.1182/blood.v64.4.807.807 · Cited by 88
Roubey, R. A. S., Maldonado, M. A., & Byrd, S. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390922 · Cited by 86
Self-citationYin, E. T., & Gaston, L. W. (1965) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1654857 · Cited by 84
Exner, T., Sahman, N., & Trudinger, B. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80596-5 · Cited by 82
Vermylen, J., & Arnout, J. (1992) · PubMed · Cited by 79
Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein
Sammaritano, L. R., Gharavi, A. E., Soberano, C., Levy, R. A., & Lockshin, M. D. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918270 · Cited by 77
Characterization of binding of human β2-glycoprotein I to cardiolipin
Kertész, Z., Yu, B., Steinkasserer, A., HAUPT, H., Benham, A. M., & Sim, R. B. (1995) · Biochemical Journal · doi:10.1042/bj3100315 · Cited by 63
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
Violi, F., Ferro, D., Valesini, G., Quintarelli, C., Saliola, M., Grandilli, M. A., & BALSANO, F. (1990) · BMJ · doi:10.1136/bmj.300.6732.1099 · Cited by 61
Thoughts on the Mechanism of Pregnancy Loss Associated with the Antiphospholipid Syndrome
Branch, D. W. (1994) · Lupus · doi:10.1177/096120339400300414 · Cited by 57
Lupus‐like anticoagulant properties of murine monoclonal antibodies to β2‐glycoprotein I
Arvieux, J., Pouzol, P., Roussel, B., Jacob, M., & Colomb, M. G. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb02993.x · Cited by 52
Loizou, S., COFINER, C., Weetman, A. P., & Walport, M. J. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb05864.x · Cited by 46
Shibata, S., Sasaki, T., Harpel, P. C., & Fillit, H. M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1018 · Cited by 45
Factor V inhibitor in thrombosis
Kapur, A., Kelsey, P. R., & Isaacs, P. E. T. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830420410 · Cited by 44
Endothelial-Dependent Fibrinolysis in Subjects with the Lupus Anticoagulant and Thrombosis
Francis, R. B., McGehee, W., & Feinstein, D. I. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647506 · Cited by 41
Fillit, H. M., Shibata, S., Sasaki, T., Spiera, H., Kerr, L. D., & Blake, M. S. (1993) · Autoimmunity · doi:10.3109/08916939309077372 · Cited by 34
Inhibition of prothrombin activation by antiphospholipid antibodies and β2‐glycoprotein 1
Goldsmith, G. H., Pierangeli, S. S., Branch, D. W., Gharavi, A. E., & Harris, E. N. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08311.x · Cited by 32
Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus Erythematosus
Fillit, H. M., & Lahita, R. G. (1991) · Autoimmunity · doi:10.3109/08916939109006752 · Cited by 29
Species specificity of lupus-like anticoagulants
Clyne, L. P. (1986) · Annals of Hematology · doi:10.1007/bf00320886 · Cited by 6
Cited by
Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,543
Adhesion mechanism of human beta 2-glycoprotein I to phospholipids based on its crystal structure
Bouma, B. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5166 · Cited by 333
Antibody profiles for the diagnosis of antiphospholipid syndrome
Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F., Iliceto, S., & Pengo, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0839 · Cited by 320
Di Simone, N., Meroni, P. L., Del Papa, N., Raschi, E., Caliandro, D., De Carolis, S., Khamashta, M. A., Atsumi, T., Hughes, G. R. V., Balestrieri, G., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<140::aid-anr18>3.0.co;2-p · Cited by 316
Antiphospholipid syndrome: multiple mechanisms
MACKWORTH-YOUNG, C. G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02497.x · Cited by 114
Metadata
- Authors
- Roubey, R. A. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-09
- Volume
- 39
- Issue
- 9
- Pages
- 1444-1454
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1994284943
- Cited by
- 302
- References
- 97
- FWCI
- 23.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.